Upjohn Ltd contra The Licensing Authority established by the Medicines Act 1968 y otros.

Core Citations

WORK EXPRESSION OF in

• Upjohn Ltd contra The Licensing Authority established by the Medicines Act 1968 y otros.

This document cites

• The Queen contra Licensing Authority of the Department of Health y Norgine Ltd, ex parte Scotia Pharmaceuticals Ltd.
• Peterbroeck, Van Campenhout & Cie SCS contra Estado belga.
• Theresa Emmott contra Minister for Social Welfare y Attorney General.
• Pierrel SpA y otros contra Ministero della Sanità.
• United Kingdom of Great Britain and Northern Ireland v Council of the European Union.



See all quotations

• Procedimento penal entablado contra Paul Vandevenne, Marc Wilms, Jozef Mesotten y Wilms Transport NV.
• Norbrook Laboratories Ltd contra Ministry of Agriculture, Fisheries and Food.
• The Queen contra The Medicines Control Agency, ex parte Smith & Nephew Pharmaceuticals Ltd y Primecrown Ltd contra The Medicine Control Agency.
• Jeroen van Schijndel y Johannes Nicolaas Cornelis van Veen contra Stichting Pensioenfonds voor Fysiotherapeuten.
• Council Directive 93/39/EEC of 14 June 1993 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC in respect of medicinal products
• Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products
• Council Directive 83/570/EEC of 26 October 1983 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products
• Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products
• Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products